An optimized polyamine moiety boosts the potency of human type II topoisomerase poisons as quantified by comparative analysis centered on the clinical candidate F14512.
暂无分享,去创建一个
A. Minarini | M. Rosini | G. Palermo | Laura Riccardi | M. De Vivo | M. L. Greco | C. Sissi | E. Simoni | M. Convertino | C. Marchetti | E. Minniti